Caren van Roekel

159 Mode of progression after radioembolization in colorectal cancer patients 38. Firth D. Bias reduction of maximum likelihood estimates. Biometrika. 1993;89(1):27-38. 39. Seidensticker R, Denecke T, Kraus P, Seidensticker M, Mohnike K, Fahlke J, et al. Matched-pair comparison of radioembolization plus best supportive care versus best supportive care alone for chemotherapy refractory liver-dominant colorectal metastases. Cardiovasc Interv Radiol. 2012;35(5):1066-73. 40. Kennedy AS, Ball DS, Cohen SJ, Cohn M, Coldwell DM, Drooz A, et al. Hepatic imaging response to radioembolization with y t trium-90 -labeled resin microspheres for tumor progression during systemic chemotherapy in patients with colorectal liver metastases. J Gastrointest Oncol. 2015;6(6):594-604. 41. Lewandowski RJ, Memon K, Mulcahy MF, Hickey R, Marshall K, Williams M, et al. Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy. Eur J Nucl Med Mol Im. 2014;41(10):1861-9. 42. Shady W, Petre EN, Gonen M, Erinjeri JP, Brown KT, Covey AM, et al. Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A10-year Experience at a Single Center. Radiology. 2016;278(2):601-11. 43. Shady W, Sotirchos VS, Do RK, Pandit- Taskar N, Carrasquillo JA, Gonen M, et al. Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres. Am J Roentgenol. 2016;207(3):661-70. 44. Seidensticker R, Damm R, Enge J, Seidensticker M, Mohnike K, Pech M, et al. Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival. BMC Cancer. 2018;18(1):882. 45. Rosenbaum CE, van den Hoven AF, Braat MN, Koopman M, Lam MG, Zonnenberg BA, et al. Yttrium-90 radioembolization for colorectal cancer liver metastases: a prospective cohort study on circulating angiogenic factors and treatment response. EJNMMI Research. 2016;6(1):92. 46. Tohme S, Sukato D, Nace GW, Zajko A, Amesur N, Orons P, et al. Survival and tolerability of liver radioembolization: a comparison of elderly and younger patients with metastatic colorectal cancer. HPB. 2014;16(12):1110-6. 47. Soydal C, Kucuk NO, Balci D, Gecim E, Bilgic S, Elhan AH. Prognostic Importance of the Presence of Early Metabolic Response and Absence of Extrahepatic Metastasis After Selective Internal Radiation Therapy in Colorectal Cancer Liver Metastasis. Cancer Biother Radiopharm. 2016;31(9):342-6. 48. Paprottka KJ, Schoeppe F, Ingrisch M, Rubenthaler J, Sommer NN, De Toni E, et al. Pre-therapeutic factors for predicting survival after radioembolization: a single- center experience in 389 patients. Eur J Nucl Med Mol Im. 2017;44(7):1185-93. 49. Mulcahy MF, Lewandowski RJ, Ibrahim SM, Sato KT, Ryu RK, Atassi B, et al. Radioembolization of colorectal hepatic metastases using yttrium-90microspheres. Cancer. 2009;115(9):1849-58. 5